상세정보
- 상세정보
Liver Intra-arterial PRRT with 111In-Octreotide The Tumoricidal Efficacy of 111In Auger Electron Emission [electronic resource]
Limouris, Georgios S
- 책이미지
-
- 도서 상세정보
- 서평쓰기
| 자료유형 | 단행본 |
|---|---|
| 개인저자 | Limouris, Georgios S.,editor. |
| 단체저자명 | SpringerLink (Online service). |
| 서명/저자사항 | Liver Intra-arterial PRRT with 111In-Octreotide [electronic resource] : The Tumoricidal Efficacy of 111In Auger Electron Emission / edited by Georgios S. Limouris. |
| 판사항 | 1st ed. 2021. |
| 형태사항 | XIII, 270 p. 130 illus., 124 illus. in color:online resource. |
| 기본자료 저록 | Springer Nature eBook |
| 기타형태 저록 | Printed edition:9783030707729Printed edition:9783030707743Printed edition:9783030707750 |
| ISBN | 9783030707736 |
| 기타표준부호 | 10.1007/978-3-030-70773-6 |
| 내용주기 | The efficacy of auger and internal conversion electron emission 0f in-111 to treat neuroendocrine tumors -- Somatostatin -- Gastro-entero-pancreatic neuroendocrine tumors -- [111in-dtpa0-d-phe1] - octreotide: the ligand -the receptor-label -- Regulations and requirements of hospitals performing radio-infusions -- Intravenous radio-peptide infusion with in-octreotide -- Intra-arterial radio-peptide infusion -- Radio-peptide infusions after implementation of an intra-arterial port system -- US, CT and MRI for the evaluation of patients with neuroendocrine tumors -- Angiographic anatomy on the course of liver intra-arterial infusion -- Liver radio-infusions: identifying anatomic variants -- Dosimetry and dose calculation: its necessity in radio-peptide therapy -- Evaluation and assessment of the radio-peptide treatment efficacy -- Intra-venous radio-peptide infusions with in-octreotide for the treatment of bronchial carcinoids -- Intra-arterial radio - peptide infusions for the treatment of colorectal carcinomas -- Intra-arterial radio-peptide infusions for the treatment of paragangliomas -- Intra-arterial radio-peptide infusions for the treatment of brain meningiomas -- Surgery in neuroendocrine tumors -- Cytoreductive surgery combined with intraperitoneal [111in-dtpa0– d-phe1]-octreotide infusions in neuroendocrine character metastases -- Patients survival followed intra-arterial versus intravenous infusions -- Complications and side effects on the course of liver-radio-infusions -- Progression free survival and response rate in neuroendocrine liver–metastasized patients, treated with in-111 octreotide -- Therapy response vs variability of tumor size, absorbed dose, and ki-67 index after in-111 octreotide intra-arterial infusions. |
| 요약 | This book describes in detail a clinical project that reveals the tumoricidal efficacy of Auger and internal conversion electrons, emitted from n.c.a. 111In and implemented in oncology as a treating armamentarium for peptide receptor radionuclide therapy (PRRT), targeting small size (ø ≤ 20 mm) tumors and micro-metastases. The keen interest in n.c.a. 111In began when it was observed that its Auger electron emission could be highly radiotoxic, due to its high LET when it decayed in the vicinity of cellular DNA. The somatostatin analog octreotide, labeled with [111In-diethylenetriaminepentaacetic acid (DTPA0-D-Phe1)] is an established diagnostic agent for the imaging of somatostatin receptor-positive neuro- (or non-neuro) endocrine tumors. It relies on receptor-mediated binding, internalization and installation in the lysosomes in the proximity of the nucleus; administered in large doses, loco-regionally, via the feeding artery of solid tumors, can be highly radiotoxic if they over-express somatostatin receptors, mainly of the sst2 histotype. The book compares the results between i.v. and i.a. implementation in more than 80 patients after over 800 i.a. infusions in neuroendocrine tumors, meningiomas, paragangliomas and colorectal carcinomas in a single Institute (Aretaieion University Hospital) and encourages the i.a. way, leading to “tumor melting”, while minimizing the toxicity to healthy peritumoral liver tissue and critical organs (kidneys and bone marrow). The volume is an invaluable tool for nuclear medicine physicians, interventional radiologists and oncologists dealing with radiopeptide therapies. . |
| 일반주제명 | Nuclear medicine. Oncology. Interventional radiology. Surgery. Nuclear Medicine. Oncology. Interventional Radiology. Surgery. |
| 바로가기 | URL |